Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens US Application 17/904,157Filed on 2021-03-04
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens South Africa2022/09477Filed on 2021-03-04
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens Singapore11202252530HFiled on 2021-03-04
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens South Korea10-2022-7034599Filed on 2021-03-04
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens China202180019311.0Filed on 2021-03-04
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens Australia2021231832Filed on 2021-03-04
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens Canada3170375Filed on 2021-03-04
Engineered Influenza Neuraminidase Antigens Read more about Engineered Influenza Neuraminidase Antigens Japan2022-554464Filed on 2021-03-04
Development Of Dengue Virus Vaccine Components Read more about Development Of Dengue Virus Vaccine Components US Application 18/355,265Filed on 2023-07-19
METHOD OF IMMMUNOFOCUSING AN IMMUNE RESPONSE Read more about METHOD OF IMMMUNOFOCUSING AN IMMUNE RESPONSE Patent Cooperation TreatyPCT/US2023/070926Filed on 2023-07-25